Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP548611.RAmH2hZMHarrE-O63lFOKENqtYH7kBIKMsXQVMj0-y-gs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP548611.RAmH2hZMHarrE-O63lFOKENqtYH7kBIKMsXQVMj0-y-gs130_assertion type Assertion NP548611.RAmH2hZMHarrE-O63lFOKENqtYH7kBIKMsXQVMj0-y-gs130_head.
- NP548611.RAmH2hZMHarrE-O63lFOKENqtYH7kBIKMsXQVMj0-y-gs130_assertion description "[In total, 21 protein spots were found to be differentially expressed following cisplatin treatment, of which 12 were upregulated (eg, regulator of G-protein signaling, TRAF:TNF (tumor necrosis factor) receptor-associated factor-interacting protein [I-TRAF], and cyclin-dependent kinase inhibitor p27 [p27(kip1)]) and 9 were downregulated (eg, myc proto-oncoprotein [c-myc] and proliferating cell nuclear antigen).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548611.RAmH2hZMHarrE-O63lFOKENqtYH7kBIKMsXQVMj0-y-gs130_provenance.
- NP548611.RAmH2hZMHarrE-O63lFOKENqtYH7kBIKMsXQVMj0-y-gs130_assertion evidence source_evidence_literature NP548611.RAmH2hZMHarrE-O63lFOKENqtYH7kBIKMsXQVMj0-y-gs130_provenance.
- NP548611.RAmH2hZMHarrE-O63lFOKENqtYH7kBIKMsXQVMj0-y-gs130_assertion SIO_000772 16681749 NP548611.RAmH2hZMHarrE-O63lFOKENqtYH7kBIKMsXQVMj0-y-gs130_provenance.
- NP548611.RAmH2hZMHarrE-O63lFOKENqtYH7kBIKMsXQVMj0-y-gs130_assertion wasDerivedFrom befree-2016 NP548611.RAmH2hZMHarrE-O63lFOKENqtYH7kBIKMsXQVMj0-y-gs130_provenance.
- NP548611.RAmH2hZMHarrE-O63lFOKENqtYH7kBIKMsXQVMj0-y-gs130_assertion wasGeneratedBy ECO_0000203 NP548611.RAmH2hZMHarrE-O63lFOKENqtYH7kBIKMsXQVMj0-y-gs130_provenance.